Yasukuni Yamada

Profile
Tenure
Apr 1978 – Jun 1999
Years in office
21.2 years
Name in Japanese
山田安邦
Title at appointment
President
Performance in office
Rohto Pharmaceutical
Performance in office
FY1978FY1999Change
Revenue¥9.5billion¥41.6billion+338%
Net margin10.3%4.9%−5.4pt
Teruo YamadaYasukuni YamadaKunio Yamada
Revenue¥7.3 billionRevenue¥15.7 billionRevenue¥21.0 billionRevenue¥67.3 billionNet margin14.3%Net margin8.1%Net margin4.2%Net margin5.6%1974/31979/31984/31989/31994/31999/32004/3
Revenue¥7.3 billionRevenue¥15.7 billionRevenue¥21.0 billionRevenue¥67.3 billionNet margin14.3%Net margin8.1%Net margin4.2%Net margin5.6%1974/31979/31984/31989/31994/31999/32004/3
API: /api/4527/financials_history.csv · /api/4527/financials/pl.json
Tenure

Tenure

Background

Born in Osaka Prefecture in 1926, he graduated from the University of Tokyo in March 1953 and joined Rohto Pharmaceutical in April of that year. Three months after joining, in July 1953, he became a Director, then served as General Manager of Advertising from June 1959 and head of the Administration Office from February 1962 before becoming Executive Vice President in November of that year. In the fiscal year ended March 1975 Yasukuni Yamada was the largest shareholder at 13.35%, followed by Yasunobu Yamada at 7.95%, Yasusada Yamada at 7.91%, Yasumasa Yamada at 7.87% and Yasuhiro Yamada at 7.85%. He held the largest stake within the family.

Education: University of Tokyo, Faculty of Economics (1953)

Selection

In April 1978, as Teruo Yamada became Chairman, he succeeded him as President. It had been 25 years since he joined in 1953 and 15 years since he became Executive Vice President. In the same month, April 1978, Heihachiro Yamamoto became Executive Vice President, and in June Yasuhiro Yamada became Managing Director, so the executive ranks were reshuffled all at once. Non-consolidated net sales were ¥9.23 billion in the fiscal year ended March 1977 and ¥9.49 billion in FY ended March 1978, so the change does not appear to have been prompted by a downturn.

Initiatives

In 1988 he acquired Mentholatum of the US, buying the brand, whose usage rights the company had licensed in 1975, at its source. Non-consolidated net sales grew 4.4-fold, from ¥9.49 billion in the fiscal year ended March 1978, his predecessor's last year, to ¥41.6 billion in FY ended March 1999. Net income fell to ¥0.61 billion in FY ended March 1993 and recovered to ¥2.19 billion in FY ended March 1998. In June 1999 he stepped back to Chairman and handed the presidency to Kunio Yamada.

Career

Career

Rohto Pharmaceutical

Date Position
Apr 1953 Joined
Jul 1953 Director
Jun 1959 General Manager, Advertising Department
Feb 1962 General Manager, Administration Office
Nov 1962 Executive Vice President
Apr 1978 President
References 2

References (Japanese primary sources)